Compare AXT Inc (AXTI) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AXT Inc vs Mesoblast Limited — how do they compare? AXT Inc trades at $78.63 (market cap $4.83B), while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: AXT Inc is far larger — about 2.2× Mesoblast Limited's market cap. Which is the better fit depends on your goals.
| AXTI | MESO | |
|---|---|---|
Market Cap | $4.83B | $2.21B |
Sector | Technology | Technology |
52-Week High | $140.83 | $20.96 |
52-Week Low | $2.05 | $12.88 |
Enterprise Value | $4.50B | $2.21B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AXT Inc
AXT develops and manufactures high-performance compound semiconductor wafer substrates. Its products, like indium phosphide and gallium arsenide, are essential for data centers, 5G, and consumer electronics.
Read more on AXTI →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
